972 related articles for article (PubMed ID: 8444414)
1. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
[TBL] [Abstract][Full Text] [Related]
2. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
3. Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis.
Klein R; Eisenburg J; Weber P; Seibold F; Berg PA
Hepatology; 1991 Dec; 14(6):1147-52. PubMed ID: 1720413
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.
Granito A; Muratori P; Muratori L; Pappas G; Cassani F; Worthington J; Ferri S; Quarneti C; Cipriano V; de Molo C; Lenzi M; Chapman RW; Bianchi FB
Aliment Pharmacol Ther; 2007 Sep; 26(6):831-8. PubMed ID: 17767467
[TBL] [Abstract][Full Text] [Related]
6. Antilactoferrin antibodies in autoimmune liver diseases.
Ohana M; Okazaki K; Hajiro K; Uchida K
Am J Gastroenterol; 1998 Aug; 93(8):1334-9. PubMed ID: 9707061
[TBL] [Abstract][Full Text] [Related]
7. Anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver disease.
Mulder AH; Horst G; Haagsma EB; Kleibeuker JH; Kallenberg CG
Adv Exp Med Biol; 1993; 336():545-9. PubMed ID: 8296673
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibodies in juvenile chronic arthritis.
Mulder L; van Rossum M; Horst G; Limburg P; de Graeff-Meeder ER; Kuis W; Kallenberg C
J Rheumatol; 1997 Mar; 24(3):568-75. PubMed ID: 9058667
[TBL] [Abstract][Full Text] [Related]
9. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
[TBL] [Abstract][Full Text] [Related]
10. Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients.
Lohse AW; Gerken G; Mohr H; Löhr HF; Treichel U; Dienes HP; Meyer zum Büschenfelde KH
Z Gastroenterol; 1995 Sep; 33(9):527-33. PubMed ID: 8525656
[TBL] [Abstract][Full Text] [Related]
11. [Immunological diagnosis in non-viral liver diseases].
Berg PA; Klein R
Schweiz Rundsch Med Prax; 1992 Jun; 81(24):793-4. PubMed ID: 1604096
[TBL] [Abstract][Full Text] [Related]
12. Nuclear antigens recognized by antibodies present in liver disease sera.
Penner E; Kindas-Mügge I; Hitchman E; Sauermann G
Clin Exp Immunol; 1986 Feb; 63(2):428-33. PubMed ID: 3516468
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass.
Bansi D; Chapman R; Fleming K
J Hepatol; 1996 May; 24(5):581-6. PubMed ID: 8773914
[TBL] [Abstract][Full Text] [Related]
14. [Incidence and prevalence of autoimmune liver diseases].
Berdal JE; Ebbesen J; Rydning A
Tidsskr Nor Laegeforen; 1998 Nov; 118(29):4517-9. PubMed ID: 9889636
[TBL] [Abstract][Full Text] [Related]
15. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis.
Stechemesser E; Klein R; Berg PA
Hepatology; 1993 Jul; 18(1):1-9. PubMed ID: 8325600
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens?
Seibold F; Weber P; Schöning A; Mörk H; Goppel S; Scheurlen M
Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1095-100. PubMed ID: 8944372
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases.
Claise C; Johanet C; Bouhnik Y; Kapel N; Homberg JC; Poupon R
Liver; 1996 Feb; 16(1):28-34. PubMed ID: 8868075
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.
Papp M; Sipeki N; Vitalis Z; Tornai T; Altorjay I; Tornai I; Udvardy M; Fechner K; Jacobsen S; Teegen B; Sumegi A; Veres G; Lakatos PL; Kappelmayer J; Antal-Szalmas P
J Hepatol; 2013 Sep; 59(3):457-66. PubMed ID: 23639483
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F
Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
[TBL] [Abstract][Full Text] [Related]
20. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis.
Bedlow AJ; Donaldson PT; McFarlane BM; Lombard M; McFarlane IG; Williams R
J Clin Lab Immunol; 1989 Nov; 30(3):103-9. PubMed ID: 2642168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
